GlassScriptPhysician profile
Sarah Elizabeth Hicks
NPI 1013914837
$1,024.72
in general payments reported to CMS, 2019-2025
20 companies · $92.42 in 2025
The $92.42 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $466 · 2023: $102 · 2025: $92.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $154.47 | 2021-2025 | Tecvayli, Talvey |
| Astellas Pharma US INC | $144.61 | 2021 | |
| Celgene Corporation | $136.55 | 2022-2023 | Reblozyl |
| Ethicon US, LLC | $120.34 | 2022 | |
| Incyte Corporation | $109.46 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $87.59 | 2022 | |
| Merck Sharp & Dohme LLC | $38.60 | 2021 | |
| Allergan, INC. | $30.67 | 2021 | |
| Global Blood Therapeutics, INC. | $20.95 | 2021 | |
| Amgen INC. | $20.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.74 | 2023 | Libtayo |
| Dendreon Pharmaceuticals LLC | $18.79 | 2021 | |
| Pfizer INC. | $17.94 | 2025 | |
| Seagen INC. | $17.85 | 2023 | Tukysa |
| Travere Therapeutics, INC. | $15.61 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $15.09 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $14.74 | 2022 | |
| Morphosys, US INC. | $14.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.71 | 2023 | |
| Boston Scientific Corporation | $12.71 | 2023 | Rezum Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.